Response Assessment in Solid Tumours (RECIST): Version 1.1 and supporting papersEISENHAUER, E; VERWEIJ, J; THERASSE, P et al.European journal of cancer (1990). 2009, Vol 45, Num 2, issn 0959-8049, 88 p.Serial Issue

Recommendations for the assessment of progression in randomised cancer treatment trialsDANCEY, J. E; DODD, L. E; FORD, R et al.European journal of cancer (1990). 2009, Vol 45, Num 2, pp 281-289, issn 0959-8049, 9 p.Article

Evaluation of lymph nodes with RECIST 1.1SCHWARTZ, L. H; BOGAERTS, J; FORD, R et al.European journal of cancer (1990). 2009, Vol 45, Num 2, pp 261-267, issn 0959-8049, 7 p.Article

Lessons learned from independent central reviewFORD, R; SCHWARTZ, L; VERWEIJ, J et al.European journal of cancer (1990). 2009, Vol 45, Num 2, pp 268-274, issn 0959-8049, 7 p.Article

Validation of novel imaging methodologies for use as cancer clinical trial end-pointsSARGENT, D. J; RUBINSTEIN, L; SCHWARTZ, L et al.European journal of cancer (1990). 2009, Vol 45, Num 2, pp 290-299, issn 0959-8049, 10 p.Article

New response evaluation criteria in solid tumours : Revised RECIST guideline (version 1.1)EISENHAUER, E. A; THERASSE, P; RUBINSTEIN, L et al.European journal of cancer (1990). 2009, Vol 45, Num 2, pp 228-247, issn 0959-8049, 20 p.Article

A simulation study to evaluate the impact of the number of lesions measured on response assessmentMOSKOWITZ, Chaya S; XIAOYU JIA; SCHWARTZ, Lawrence H et al.European journal of cancer (1990). 2009, Vol 45, Num 2, pp 300-310, issn 0959-8049, 11 p.Article

Individual patient data analysis to assess modifications to the RECIST criteriaBOGAERTS, Jan; FORD, Robert; SARGENT, Dan et al.European journal of cancer (1990). 2009, Vol 45, Num 2, pp 248-260, issn 0959-8049, 13 p.Article

Optimising the design of phase II oncology trials : The importance of randomisationRATAIN, Mark J; SARGENT, Daniel J.European journal of cancer (1990). 2009, Vol 45, Num 2, pp 275-280, issn 0959-8049, 6 p.Article